HS_GTF2H4_1435495 QuantiNova LNA PCR Assay

GeneGlobe ID: SBH0191703 | Cat. No.: Varies | QuantiNova LNA PCR Assays for Real-Time PCR

Product Specification

Best coverage assay for GTF2H4
Assay targets 4 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.

null
Assay name​
HS_GTF2H4_1435495 QuantiNova LNA PCR Assay
Wet-lab verified​
no
Assay specification​
Best coverage assay for GTF2H4
Assay targets 4 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.
Gene symbol​
GTF2H4
Species​
Homo sapiens
Main target​
ENST00000468446
Exons numbers​
1-3
Ensembl exons ids​
ENSE00001835476, ENSE00003634267, ENSE00003563328
Amplicon start​
233
Amplicon length​
88
Assay targets​
Transcript Ensembl Id
Bio Type
Ccds
Ref Seq
Chromosome Location
ENST00000435498
Protein coding
Chr.CHR_HSCHR6_MHC_MANN_CTG1: 30952864 - 30958749
ENST00000456968
Protein coding
Chr.CHR_HSCHR6_MHC_MANN_CTG1: 30952827 - 30958749
ENST00000468446
Retained intron
Chr.CHR_HSCHR6_MHC_MANN_CTG1: 30956866 - 30958749
ENST00000469920
Retained intron
Chr.CHR_HSCHR6_MHC_MANN_CTG1: 30956594 - 30958749

Resources

User Manuals (1)
Safety Data Sheets (1)
Download Safety Data Sheets for QIAGEN product components.
Certificates of Analysis (1)
Introducing the HS_GTF2H4_1435495 QuantiNova LNA PCR Assay, a cutting-edge addition to our QuantiNova LNA PCR Assays for Real-Time PCR lineup, specifically designed for RNA expression applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the HS_GTF2H4_1435495 QuantiNova LNA PCR Assay facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting RNA expression, or any other sophisticated analyses, this product from our QuantiNova LNA PCR Assays for Real-Time PCR collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with HS_GTF2H4_1435495 QuantiNova LNA PCR Assay and elevate your work to new heights.